The theme for the upcoming 2021 the Japanese Society of Medical Oncology Annual Meeting is “Evolving treatment paradigms for precision oncology”. In 2019, insurance coverage for oncogene panel testing was made available in Japan, and the 17th annual JSMO meeting focused on cancer genome treatment with the theme of “Novel, Challenge and Change”. During this gathering, many relevant presentations regarding its implementations were presented generating interest and discourse from the participants.
At the 18th Academic Meeting in February 2021, we would like to follow-up on the real-world experience of oncogene panel testing, 1-2 years after its implementation, by examining the its results and discuss on making improvements and enhancements on its applications.